These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12151074)

  • 1. The in vitro metabolism of thalicarpine, an aporphine-benzyltetrahydroisoquinoline alkaloid, in the rat. API-MS/MS identification of thalicarpine and metabolites.
    Wu WN; McKown LA
    J Pharm Biomed Anal; 2002 Aug; 30(1):141-50. PubMed ID: 12151074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic biotransformation of the new calcium-mimetic agent, RWJ-68025, in the rat and in man--API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Rybczynski PJ; Demarest K
    J Pharm Pharmacol; 2003 May; 55(5):631-7. PubMed ID: 12831505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro metabolism of the new anxiolytic agent, RWJ-52763 in human hepatic S9 fraction-API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Reitz AB
    J Pharm Biomed Anal; 2003 Feb; 31(1):95-102. PubMed ID: 12560053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic metabolism of the new antipsychotic agent, mazapertine, in rat--API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2003; 28(4):279-86. PubMed ID: 14743969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro biotransformation of the new antipsychotic agent, RWJ-46344 in rat hepatic S9 fraction: API-MS/MS/MS identification of metabolites.
    Wu WN; McKown LA; Moyer MD; Reitz AB
    J Pharm Biomed Anal; 2000 Dec; 24(2):307-16. PubMed ID: 11130209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human hepatic metabolism of the anxiolytic agent, RWJ-51521--API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2004; 29(4):257-62. PubMed ID: 15726887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metabolism of mifepristone (RU-486) in rat, monkey and human hepatic S9 fractions: identification of three new mifepristone metabolites.
    Wu WN; McKown LA; Moyer MD; Johannsen TB; Takacs AR
    Xenobiotica; 1999 Nov; 29(11):1089-100. PubMed ID: 10598744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro biotransformation of the analgesic agent, RWJ-51784, in rat, dog and human.
    Wu WN; McKown LA; Carson JR
    Eur J Drug Metab Pharmacokinet; 2003; 28(2):107-11. PubMed ID: 12877567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro metabolism of isotetrandrine, a bisbenzylisoquinoline alkaloid, in rat hepatic S9 fraction by high-performance liquid chromatography-atmospheric pressure ionization mass spectrometry.
    Wu WN; McKown LA; Gopaul VS
    J Pharm Pharmacol; 2004 Jun; 56(6):749-55. PubMed ID: 15231040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the new alpha-1A-adrenergic receptor antagonist, phthalimide-phenylpiperazine analog (RWJ-69442), in rat, dog and human hepatic S9 fractions, and in rats.
    Wu WN; McKown LA; Kuo GH
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):113-20. PubMed ID: 16010870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the antineoplastic and immunosuppressive drug 2-CdA (Leustatin) in animals and humans.
    Wu WN; McKown LA; Moyer MD; Cheung W
    Xenobiotica; 2004 Jun; 34(6):591-606. PubMed ID: 15277018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro metabolism of the analgesic agent, RWJ-37874, in rat and human.
    Wu WN; McKown LA; Carson JR
    Eur J Drug Metab Pharmacokinet; 2003; 28(2):101-5. PubMed ID: 12877566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial transformations of natural antitumor agents. 3. Conversion of thalicarpine to (+)-hernandalinol by Streptomyces punipalus.
    Nabih T; Davis PJ; Caputo JF; Rosazza JP
    J Med Chem; 1977 Jul; 20(7):914-7. PubMed ID: 141523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro metabolism of the new anxiolytic agent, RWJ-50172, in rat hepatic S9 fraction and microbial transformation in fungi, Cunninghamella sp.
    Wu WN; McKown LA; Melton JL; Reitz AB
    J Pharm Pharmacol; 2003 Aug; 55(8):1099-105. PubMed ID: 12956899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic metabolism of two alpha-1A-adrenergic receptor antagonists, phthalimide-phenylpiperazine analogs (RWJ-69205 and RWJ-69471), in the rat, dog and human.
    Wu WN; McKown LA; Kuo GH
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):271-6. PubMed ID: 17315538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrospray tandem mass spectrometry for structural characterization of aporphine- benzylisoquinoline alkaloids.
    Wu WN; Moyer MD
    Eur J Mass Spectrom (Chichester); 2004; 10(5):683-9. PubMed ID: 15531802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of the analgesic drug ULTRAM (tramadol hydrochloride) in humans: API-MS and MS/MS characterization of metabolites.
    Wu WN; McKown LA; Liao S
    Xenobiotica; 2002 May; 32(5):411-25. PubMed ID: 12065063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of the alpha-1A-adrenergic receptor antagonist, pyridine-phenylpiperazine analog (RWJ-69597), in rat, dog and human hepatic S9 fractions -API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Kuo GH
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):105-11. PubMed ID: 16010869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic fate of the antipsychotic agent, mazapertine, in man--API-MS and MS/MS identification of urinary metabolites.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2007; 32(3):171-6. PubMed ID: 18062409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.